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Abstract
Background: The virulent vector-borne disease, Gambian human African trypanosomiasis (HAT), is one of several
diseases targeted for elimination by the World Health Organization. This article utilises human case data from a
high-endemicity region of the Democratic Republic of Congo in conjunction with a suite of novel mechanistic
mathematical models to address the effectiveness of on-going active screening and treatment programmes and
compute the likely time to elimination as a public health problem (i.e. <1 case per 10,000 per year).
Methods: The model variants address uncertainties surrounding transmission of HAT infection including heterogeneous
risk of exposure to tsetse bites, non-participation of certain groups during active screening campaigns and potential
animal reservoirs of infection.
Results: Model fitting indicates that variation in human risk of tsetse bites and participation in active screening play a
key role in transmission of this disease, whilst the existence of animal reservoirs remains unclear. Active screening
campaigns in this region are calculated to have been effective, reducing the incidence of new human infections by
52–53 % over a 15-year period (1998–2012). However, projections of disease dynamics in this region indicate that the
elimination goal may not be met until later this century (2059–2092) under the current intervention strategy.
Conclusions: Improvements to active detection, such as screening those who have not previously participated and
raising overall screening levels, as well as beginning widespread vector control in the area have the potential to ensure
successful and timely elimination.
Keywords: Sleeping sickness, Gambian human African trypanosomiasis, Mathematical model, Basic reproductive ratio,
Elimination, Democratic Republic of Congo
Background
The London Declaration on Neglected Tropical Diseases
[1, 2] lists human African trypanosomiasis (HAT) as one
of the diseases targeted for “elimination”. In the case of
HAT, the elimination target is defined as “the reduction
of gambiense HAT incidence to less than 1 new case per
10,000 population at risk, in at least 90 % of foci with
fewer than 2000 cases reported globally” by 2020 and “to
target zero incidence of the disease by 2030” [3]. HAT is
caused by subspecies of Trypanosoma brucei, a proto-
zoan parasite transmitted by tsetse flies (Glossina spp.).
While the single name “sleeping sickness” is commonly
used, the disease exists in two distinct forms. Most
(>98 %) cases occur in West and Central Africa and are
caused by T. b. gambiense transmitted by the riverine
species of tsetse. This Gambian form of the disease is
generally regarded as an anthroponosis [4], although
parasites are sometimes detected in non-human hosts
and could play a role in transmission [5]. The remaining
2 % of cases are caused by T. b. rhodesiense transmitted
by savanna species of tsetse. Rhodesian HAT is a zoo-
nosis typically associated with the wilderness areas of
East and Southern Africa where tsetse vectors, wild res-
ervoir hosts (e.g., warthog, buffalo) and occasionally cat-
tle are abundant. The zoonotic nature of Rhodesian
HAT means that complete elimination of the disease is
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unlikely [3]. Hence, the goal of elimination is specific to
Gambian HAT.
The global number of reported cases per year is in line
with the goal of elimination. WHO’s target is for a
steady decline to 2,000 cases per year by 2020: the target
for 2014 was 5,000 cases [6] compared to a reported
number of 3,679 [7]. The last bastion of Gambian HAT
is the Democratic Republic of Congo (DRC) where 87 %
(3,206/3,679) of all cases reported in 2014 occurred. The
results for 2014 are typical for the last 15 years (2000–
2014): cases of HAT from the DRC have been between
58 % (11,481/19,963 in 2003) and 91 % (5,647/6,228 in
2013) of all cases reported globally [7]. Within DRC it-
self, the distribution of HAT is also highly heteroge-
neous with three provinces being particularly important.
Of the 127,960 cases reported from DRC between 2000
and 2012, 46 % (58,585 cases) came from Bandundu
province, 21 % (26,692 cases) from Kasaï (East and
West) and 17 % (21,575) from Équateur [8]. Achieving
the global elimination goal for Gambian HAT therefore
depends on the impact of interventions in the DRC and
these three provinces in particular.
Control of Gambian HAT in DRC, as elsewhere, has
depended almost exclusively on active case detection
and treatment [9]. In the DRC for instance, more than
24 million people were screened between 2000 and 2012
[8]. As HAT disease progresses through two distinct
stages, each with different treatments (pentamindine for
stage 1 and nifurtimox and eflorithine combination
treatment (NECT) for stage 2), diagnosis therefore in-
volves the use of multiple diagnostic tools. Diagnostic al-
gorithms vary across space and time, however key steps
include screening for infection usually via the card ag-
glutination test for trypanosomes performed on whole
blood (CATT-WB), visual confirmation of the parasite
using microscopy, and “staging” disease via a lumbar
puncture; if more than 5 white cells per μ l (microlitre)
or trypanosomes are identified in cerebral spinal fluid
then the patient has stage 2 disease [9]. In addition to
these large-scale active programmes, some individuals
self-present at medical centres following onset of symp-
toms of which the worst (i.e. neurological systems) occur
in stage 2; this is referred to as “passive” detection. His-
torically, vector control has not played an important role
because of the cost and logistical complexities of trad-
itional methods of tsetse control [10] and the emphasis
on active screening continues to date. A key issue is
whether continuing the current strategy is likely to result
in the elimination of Gambian HAT in the DRC. To ad-
dress this question we have developed and applied a math-
ematical model of HAT to data from Yasa-Bonga and
Mosango Districts in the Bandundu Province of DRC.
The use of models to analyse vector-borne diseases
originates with the Ross-Macdonald equation for malaria
[11–14] and developments of this model have formed
the basis of several models of HAT (see review by [15]).
Models of HAT differ from those of malaria in two im-
portant respects reflecting differences in the underlying
biology of the two diseases. First, tsetse flies are suscep-
tible to infection with T. brucei sspp. when they take
their first blood from an infected host but are much less
susceptible for subsequent blood-meals. Indeed some
models assume that tsetse are susceptible at their first
feed only and completely refractory thereafter [16, 17].
Some studies have shown that older flies can be infected
and go on to develop mature infections but the extent of
this feature in nature is uncertain [18]. There is however
widespread agreement that there is a marked “teneral
phenomenon” whereby susceptibility declines with the
fly’s age [19]. Second, it is generally assumed that
humans are the only host for T. b. gambiense. Again em-
pirical data suggest that this might not always be the
case: T. b. gambiense has been detected in wildlife [20]
and livestock [21, 22] and experimental infections with
T. b. gambiense have shown that they retain their patho-
genicity to humans even after repeated passage through
pigs [23–25]. The epidemiological significance of these
empirical data is uncertain, but previous modelling has
suggested that it is possible that such infected animals
may be an important reservoir of infection [5]. Hence
the teneral phenomenon and the potential for non-
humans to act as hosts for trypanosomes need to be in-
corporated into models of HAT.
Model predictions for the impact of active screening
on the incidence of HAT are dependent on key assump-
tions regarding the heterogeneity of the human popula-
tion in relation to (i) their exposure to infection and (ii)
their willingness to be screened. It is widely recognised
that some groups of people are more likely to be bitten
than others. For instance, it is self-evident that people
with occupations that require them to spend extended
periods in riverine habitats (e.g., fishermen, women car-
rying out domestic chores such as washing and collect-
ing water) are more likely to be bitten than those who
never enter such tsetse-infested habitats. Screening of
local populations seldom exceeds 70 % despite efforts to
mobilize and encourage the population to attend [26,
27] and there are strong indications that some groups
(e.g. working adults) are consistently under represented
[27]. While these observations suggest that there are
strong heterogeneities in the human population, the ex-
tent of this is not well quantified and likely to vary be-
tween settings.
Our understanding of the biology, behaviour and ecol-
ogy of some species of tsetse is relatively good [4, 28].
However, the important vector of T. b. gambiense in
Yasa Bonga and Mosango is G. fuscipes quanzensis and
for this species there are scant empirical data. Some
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aspects of the basic biology of all species of tsetse are
very similar (e.g. producing a single offspring at ~9 day
intervals, both sexes taking bloodmeals at ~3 day inter-
vals) and we can be reasonably confident in applying
general values derived from one closely related species
(e.g. G. f. fuscipes) to provide parameter estimates such
as the underlying daily mortality and feeding interval of
G. f. quanzensis. On the other hand, there are some
values that apply to G. f. quanzensis for which there is
much less certainty and these need to be inferred during
model fitting to data: e.g. the transmission efficiencies of
trypanosomes between tsetse and humans and the ratio
of vectors to humans.
Robust mathematical models, in conjunction with
rigorous statistical fitting to available data are fundamen-
tal tools for modern public-health decision makers in
many counties [29–32]. Until recently, this approach has
had limited impact on health policy in impact in low-
and middle-income countries and has been largely over-
looked in the study of NTDs (although onchocerciasis
[33] is a notable exception). The basic principles are to
(i) develop a mechanistic mathematical framework that
captures the salient aspects of known biology and epi-
demiology, (ii) match this model to available data, and
(iii) use the model to predict forwards in time allowing
multiple control options to be investigated. Here we
apply these concepts to HAT in the DRC, to investigate
the potential of current controls to achieve the WHO
2020 goals – elimination of HAT as a public health
problem (less than one case per ten thousand per year)
by 2020.
Many epidemiologists are familiar with statistical
models, and the methods surrounding matching such
models to data. Mechanistic mathematical models are
simply another type of statistical model, but one in
which our knowledge and assumptions about the under-
lying processes are explicitly formulated. This has two
profound implications; the first is that in matching models
and data the parameter values inferred generally relate to
specific physical quantities such as average infectious pe-
riods or rates of transmission. The second is that when
using the model to extrapolate forwards in time, it is pos-
sible to change some of these fundamental parameters
and hence mimic the effects of control mechanisms.
Like any statistical fitting and extrapolation, different
models may produce different results – just as fitting lin-
ear and non-linear statistical models can generate very dif-
ferent conclusions. Given that there is no right model that
can capture every element of the transmission process,
and since many of the mechanisms are unknown for
HAT, it is vitally important that multiple modelling as-
sumptions are tested against the available data.
In this article, a range of hypotheses are tested utilising
data from a HAT-endemic region of the DRC in
conjunction with mathematical models that can capture
different assumptions about tsetse biology and behav-
iour, population level heterogeneities, and the potential
existence of animal reservoirs. Under each scenario, dis-
ease dynamics are projected forwards to determine the
likely time to elimination as a public health problem and
if this 2020 goal can be met for HAT.
Methods
Data
Bandundu province accounted for almost half of the re-
ported HAT cases in the DRC between 2000–2012. For
this reason the region is of great interest when consider-
ing elimination goals. For the purposes of public health
services, provinces of the DRC are partitioned into
smaller administrative units known as “Zones de Santé”
or health zones. Two health zones within Bandundu,
Yasa-Bonga and Mosango, with a combined population
of 291,567 [34, 35] are considered in this article. The
WHO Atlas data for these health zones cover the years
2000–2012 and detail the total number of actively and
passively detected cases in addition to the number of
people actively screened across these areas [36, 37]. Dur-
ing these years, active detection and treatment formed
the primary component of HAT control programmes in
this area with no large-scale vector control interventions
being implemented [8].
During model simulation and fitting, the aggregate
data from across both the health zones was used. The
percentage of the population screened was taken to be
the total reported number screened from the WHO
Atlas relative to the estimated constant population size
for the combined health zones. From this, the reported
incidence per 10,000 people per year was also computed
and shown in relation to the WHO 2020 goal of elimin-
ation as a public health problem (see Fig. 1).
Model variants
A mechanistic, compartmental model which describes
the infection dynamics in the population was developed
(see Fig. 2 and full equations in SI Section 1). This
model and its variants are based on a Ross-Macdonald-
type formulation [11–14] with infection stages in
humans, tsetse and potentially animals. In all cases the
tsetse population was partitioned into four distinct clas-
ses: teneral (unfed) flies, SV; non-teneral (previously fed)
and uninfected flies, GV; exposed (infected but non-
infective) flies, EV; and infective flies, IV. As described
previously, the teneral phenomenon means that fed tse-
tse are less susceptible than their teneral counterparts
and so the force of infection towards them is scaled by a
factor ε (< 1). The model incorporates natural disease
history in humans following infection with individuals
progressing through the classes: susceptible, SH; exposed,
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Fig. 1 The top figure shows the total level of screening and detection in the Yasa-Bonga and Mosango health zones between 2000 and 2012.
The bottom figure shows the annual incidence based on an assumed population size of 289,030 in relation to the WHO 2020 goal of elimination
as a public health problem (shown in green)
Fig. 2 Multi-host model of HAT with various host groups able to acquire and transmit HAT infection (humans and reservoir animals), further
non-reservoir animal species (others) and tsetse. Human hosts follow the progression which includes an infectious stage 1 disease, IH1, infectious
stage 2 disease , IH2, and a non-infectious (due to hospitalisation) disease, RH. Unfed tsetse are susceptible, SV, and following a blood-meal become
either exposed, EV, or have reduce susceptibility to the trypanosomes , GV. Tsetse select their blood-meal from one of the host species. Any
blood-meals taken upon non-reservoir hosts do not result in infection. The transmission of infection between humans/tsetse and reservoirs/tsetse
is shown by grey paths. Additional humans follow the same progression as the first human type but may receive more bites (high-risk) or may not
participate in screening. Transmission from additional humans to tsetse is not shown here but occurs in the same way as humans to tsetse
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EH; stage 1 infection, I1H; stage 2 infection I2H; and re-
moved (hospitalised or resting), RH. Here, both stage 1
and 2 of the disease were assumed to be equally infective
to tsetse, whereas removed individuals were not available
for blood-feeding. It was assumed that stage 2 cases ei-
ther were successfully diagnosed and treated, suffered
disease induced mortality (and were subsequently re-
placed by a new susceptible in the population) or died
due to unrelated causes (natural mortality) prior to treat-
ment; consequently all compartments only contain living
individuals. It is assumed that humans received a pro-
portion, fH, of all bites, with the rest taken on animals
that are initially assumed not to contribute to disease
transmission (non-reservoir).
There are 7 model frameworks investigated to analyse
competing hypotheses:
The simple model:
1. Homogeneous human risk and behaviour model.
This model used the standard assumption of
solely anthroponotic disease transmission and, due
to its simple formulation, provided a suitable
framework in which to investigate the impact of
teneral susceptibility and other fundamental
parameters.
Models for heterogeneous human populations:
2. High/low-risk populations. High-risk individuals
being more exposed to tsetse bites.
3. Random participation/non-participation. A fraction of
the population never participates in active screening,
while the remainder randomly participate based on
observed screening levels.
4. High-risk and non-participation/low-risk and
random participation. High-risk individuals are
precisely the ones who never participate in active
screening
5. All combinations of high/low risk and random/
non-participation. The human population is first
partitioned into low/high risk groups, and each of
these is further partitioned into those that never
participate in screening and those that randomly
participate creating four distinct human behaviour/
risk compartments.
Models for animal reservoirs:
6. Homogeneous human population and two animal
populations – a reservoir (able to acquire and
transmit disease) and a non-reservoir (which still
receive tsetse bites).
7. The model for heterogeneous human populations, as
in model 4, with additional animal reservoirs.
In all further discussion, the basic reproductive ratio,
R0
2, was computed by evaluating the square of the spec-
tral radius of the next generation matrix (NGM) (see SI
Section 2). R0
2 was chosen as a more suitable metric over
R0
2 as it is equivalent to the average number of secondary
host cases generated by a single infectious host (i.e. a full
transmission-cycle) (see [15]). R0
2 was computed in the
absence of active detection and treatment, and can be
viewed as a measure of transmission with only passive
detection occurring. No measure was given after active
screening began as the intensity of screening varied year
to year and the pulsed nature of this screening does not
allow for computation using the NGM approach.
Model fitting
Large-scale active detection campaigns in the region
under consideration started around two years before the
data began, therefore 1998 and 1999 were taken to have
the same level of screening as 2000 (see Fig. 1). Prior to
1998 it was assumed that disease was at its endemic
equilibrium (including passive detection) due to the ab-
sence of widespread intervention. The compartmental
ODE model used the reported percentage of active
screening to simulate the effect of an annual, pulsed de-
tection and treatment campaign between 1998 and 2012
in addition to passive detection and treatment. The sen-
sitivity and specificity of the active diagnostic algorithm
were taken to be 91 % and 99.9 % respectively based on
the algorithms used by MSF in the Republic of Congo,
Sudan and Uganda [38]; these algorithms involve mul-
tiple diagnostics including the Card Agglutination test
for trypanosomes on whole blood (CATT-WB) and
parasitological examination of cerebral spinal fluid from
lumbar puncture. Upon diagnosis, true positives in the
model were successfully treated (and on average were
hospitalised/stayed at home for six months, as per the
recommendation [26]), whereas false positives remained
susceptible. Passive case detection was assumed to occur
at a fixed rate with individuals self-presenting to medical
facilities after developing stage 2 disease; the rate was
chosen such that individuals remain in stage 2 for six
months on average. Whilst there is currently no robust
estimate of this period, other modelling work has esti-
mated that the duration of stage 2 disease is nine
months on average in the absence of treatment [39]. In
addition, it was assumed that there was some unknown
level of underreporting of cases, due to either diagnosed
cases not being entered into records or death before cor-
rect diagnosis (autopsies are not routinely performed to
ascertain cause of death). Estimates of underreporting
for HAT are thought to be high, possibly in excess of
50 % underreporting [37, 40, 41]. The parameter, u, is
the proportion of passive cases reported.
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The model calculates the continuous disease dy-
namics of host and vector populations (see SI Figure
S.1) and outputs the expected number of passively
detected cases (all at stage 2) across each year, PM(i),
and the expected number of actively detected cases
(both stage 1 and 2) per annual screen, AM(i) (see SI
for more details). Finally the model also computes the
actual number of new cases per year; these are newly
infected individuals as opposed to newly detected
cases. It is noted that the number of detected cases
are a product of both the natural incidence of infec-
tion and the screening effort, with these two factors
difficult to untangle in reporting data.
To compare and fit the models to the number of re-
ported (active and passive) cases, a Metropolis-Hastings
MCMC algorithm was used to calculate the posterior
mean and 95 % credible interval both for the unknown
parameters; this allows the inference of credible intervals
for the incidence of new cases each year and for the pre-
dicted years until elimination as a public health problem.
The fitting procedure estimated up to 11 unknown pa-
rameters (noting that not all are needed in all cases):
1. meff =NVpH/NH, the effective ratio of vectors to
humans if transmission probability from vector to
host were one [all models]
2. pV, the transmission probability from host to vector
[all models]
3. ε, the reduced susceptibility of non-teneral tsetse [all
models]
4. r, the relative risk (via increased proportion of bites)
of “high risk” individuals compared to “low risk”
individuals [models 2, 4, 5, 7]
5. k1, the proportion of low-risk, participating humans
[all models]
6. k2, the proportion of high-risk, participating humans
[models 2, 5]
7. k3, the proportion of low-risk, non-participating
humans [models 3, 5]
8. k4, the proportion of high-risk, non-participating
humans [models 4, 5, 7]
9. kA, the ratio of reservoir animals to humans [models
6, 7]
10.fA, proportion of feeding on reservoir animals
[models 6, 7]
11.u, proportion of passive cases reported [all models].
Other model parameters, for which there are esti-
mates available, were kept fixed and are given in
Table 1.
This fitting procedure maximised the binomial log-
likelihood function. In essence this captures the likeli-
hood that the observed active and passive cases each
year come from the appropriate random sample of the
population, where the mean is given by the deterministic
dynamics (SI Section 1). Mathematically, this log-
likelihood given by:
LL θð jxÞ∝ log ℙ xð jθð ÞÞ ¼
X2012
i¼2000ln Bin AD ið Þ; z ið ÞNH ;
AM ið Þ
NH
  
þln Bin PD ið Þ;NH ;PM ið ÞNH
  
where the model takes parameterisation θ = (meff, pV, ε, r,
k1, k2, k3, k4, kA, fA, u), x is the data, Bin(m; n, p) binomial
probability of obtaining m successes out of n trails with
probability p. PD(i) and AD(i) are the number of passive/
active cases in year i of the data, PM(i) and AM(i) are the
number of passive/active cases in year i of the model,
and z(i) is the percentage of the population screened in
year i.
The competing model structures were compared by
performing deviance information criterion DIC [42] and
computing the relative likelihood of model i using:
exp((DICmin −DICi)/2) (see SI Section S4 for more
details).
Results
Fitting models to data
The three parameters meff, pV and ε affect the predicted
incidence predominantly through their joint effect on
the basic reproductive ratio. R0
2 can be expressed as a
function of these, for the homogeneous Model 1 taking
the form:
R20 ¼ ApVmeff 1þ Bεð Þ
where A and B are constants given by the known param-
eters. The log-likelihood is not a direct function of R0
2
but there is a very strong dependence for plausible
ranges of the parameters, and the maximum log-
likelihood is achieved at the same value of the basic re-
productive ratio for all meff and pV and ε (see SI Figure
S.2). In further model simulation, the parameters pV and
ε were kept fixed at 0.065 and 0.05 respectively as they
were non-identifiable in the model fit. During the fitting
procedure, Gaussian proposals were made for R0 which
were then converted to the equivalent meff value. The
resulting best fit of model dynamics between 1998 and
2012 generated under the homogenous host population
scenario (Model 1) are shown in Fig. 3. This simple
model yielded the lowest (worst) mean log-likelihood
and highest DIC of all seven models under consideration
(see Table 2), indicating that heterogeneity in host popu-
lation(s) is needed to capture the disease dynamics
observed.
All heterogeneous human models (Models 2–5) per-
formed better than the simple model:
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Model 2 (high/low risk) fitting generated very high
values of r, the relative number of bites on high-risk in-
dividuals compared to low-risk, and very small k2, the
proportion of the population in the high-risk group,
indicating extreme levels of heterogeneity that are im-
plausible. Model 3 (random/non participation) per-
formed less well than Model 2 and only slightly better
than the simple model. Model 4 (low-risk random/high-
risk non-participation) was the best fitting heterogeneous
human model with realistic parameterisation. It was calcu-
lated that high-risk individuals were bitten r = 6.6 times
more and made up k4 = 7.6 % of the human population
(see SI Additional file 1: Table S1). This case is also shown
in Fig. 3; the generated incidence from this model is a
much better fit than under the basic homogeneous as-
sumption (Model 1). The parameters obtained for Model
5 converge to values close to those of Model 4, which is a
sub-model of this more inclusive formulation. Given that
Table 1 Parameter notation and values used in the compartmental models
Notation Description Value Source
μH Natural human mortality rate 5.4795 × 10
− 5 days− 1 [45]
BH Human birth rate μHNH -
σH Human incubation rate 0.0833 days− 1 [17]
φH Stage 1 to 2 progression rate 0.0019 days− 1 [39, 46]
γH Treatment rate from stage 2 0.006 days− 1 Assumed (see text)
u, Proportion of passive cases reported, Varies, -
Frequency of screening Annual -
Active screen diagnostic algorithm sensitivity 91 % Averaged from [38]
Active screen diagnostic algorithm sensitivity 91 % Averaged from [38]
Active screen diagnostic algorithm specificity 99.9 % Averaged from [38]
Treatment compliance 1 Assumed
ηH Pulsed active screening
ωH Recovery rate 0.006 days− 1 [27]
δH Disease induced mortality 0 Assumed
NH Total human population size 291567 [34, 35]
k1 Proportion of low-risk, random participation people Varies -
k2 Proportion of low-risk, random participation people Varies -
k3 Proportion of low-risk, random participation people Varies -
k4 Proportion of low-risk, random participation people Varies -
m Relative tsetse density NV/NH -
μV Tsetse mortality rate 0.03 days− 1 [17]
α Tsetse bite rate 0.333 days− 1 WHO 2013
σV Tsetse incubation rate 0.034 days− 1 [47, 48]
pV Probability of tsetse infection per single infective bite Varies -
pH Probability of human infection per single infective bite Varies -
meff Effective tsetse density =mpH -
ε Reduced non-teneral susceptibility factor Varies
fH Proportion of blood-meals on humans 0.09 [49] (G. fuscipes)
r Relative bites taken on “high-risk” humans compared to “low-risk” Varies -
μA Natural reservoir animal mortality rate 0.0014 days− 1 Assumed
BA Reservoir animal birth rate μANA -
σA Reservoir animal incubation rate 0.0833 days− 1 [17]
fA Proportion of blood-meals on reservoir animals Varies -
NA Reservoir animal population size Varies -
pA Probability of reservoir animal infection per single infective bite Varies -
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Model 5 does not generate a substantial improvement in
the likelihood, but requires more parameters, it has a
higher DIC. This suggests that Model 4 is the most plaus-
ible human-only model that conforms with our under-
standing of the biology of HAT.
Again, the heterogeneity introduced by allowing for two
host species (humans and reservoir animals, Model 6), sig-
nificantly improved model fit over the homogeneous hu-
man model (Model 1), however Model 6 yielded a less
good fit than Model 4. Results for Model 6 are shown as it
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forms a base-case for the inclusion of reservoir animals.
Model 7 (low-risk random/high-risk non-participation
and animals; i.e. Model 4 plus reservoir animals) generates
a slightly improved likelihood over Model 4 when fitted to
the data. The parameters of Model 7 suggest that an ani-
mal reservoir may play a small but significant role in
transmission, but this may not be necessary to explain the
data given that Model 4 fits almost as well.
Figure 3 shows best fits for the four models variants
(Models 1, 4, 6 and 7) and the reported incidence
from the WHO HAT Atlas. It is seen that Model 1 is
a poor fit to the data (N.B. the y-axis range is greater
than the data or other models). Model 4 is quantita-
tively a much better fit and generates the distinctive
peak in 2009 and dip in 2011 consistent with the
data. Models 6 and 7 qualitatively display the patterns
seen in observed cases, however Model 7 produces a
better fit than Model 6.
It is concluded that heterogeneity within the human
population is needed to generate the observed cases and
fitting suggests that individuals who are more exposed
to tsetse bites are also not participating during active
screening campaigns. Animal reservoirs alone (Model 6)
seem less able to capture the disease dynamics than het-
erogeneous human populations (Model 4), however, this
does not exclude the possibility of both heterogeneity in
humans and an animal reservoir (Model 7).
Further simulations (results not shown here), demon-
strated that the results for model choice are maintained
for other biologically plausible choices for the parame-
ters fH, the proportion of bites on humans (fH = 0.4), and
μA, the animal death rate (μA = 0.014 day
− 1). In these
simulations, the relative likelihoods are similar to those
shown in Table 2. Fitting yielded an altered range of pos-
sible values of meff, kA and fA, however there is currently
no means of discerning the most realistic ranges without
improved field or laboratory estimates for some of the
uncertain parameter values.
Predicting forwards
To establish the long-term impact of current active
screening in the area, the model was projected forward
from 2012 using either the mean or maximum level of
screening observed previously (i.e. 29.9 % or 53.6 %, re-
spectively). Under these two different scenarios the pre-
dicted time to elimination (<1 case per 10,000 people)
was computed for the Models 1, 4, 6 and 7 (Fig. 4). This
elimination year is defined here to be the first year in
which the incidence of new infections falls below 1 in 10
000 (where the green lines cross). These predicted elim-
ination years and the basic reproductive ratio, R0
2, are
given in Table 3 along with their 95 % credible intervals.
Under the homogeneous model, the target should have
already been reached as of 2014, assuming average
screening levels since 2012 (Fig. 4). However, as this
model variant is a poor fit for the data, this is deemed to
be improbable. With heterogeneity in humans, the time
to elimination becomes longer, particularly if only mean
screening levels are achieved each year. In the fitted
model without animal reservoirs (Model 4), even max-
imum screening does not achieve WHO 2020 goals, with
elimination as a public health problem being reached in
2074 (95 % CI: 2060–2092). Assuming mean screening
substantially delays the predicted elimination date for all
models (see Table 3). Including an animal reservoir con-
siderably increases the time to elimination with a homo-
geneous human population (i.e. Model 1 predicts
elimination by 2013 while Model 6 predicts 2059). How-
ever the difference in elimination years for Models 4 and
7 is small.
A key observation is that the actual incidence of new
infections is very different from the reported case inci-
dence; in particular the year in which the incidence of
new infections falls below 1 per 10,000 is not the same
as when the reported incidence is 1 per 10,000. The pas-
sive incidence is expected to cross this threshold by as
much as 74 years before the new infection incidence
Table 2 Summary of models and modelling comparison results
Model Assumptions Relative likelihood
of model (from DIC)
Notes
Humans Animals
Random participation Non-participation
Low-risk High-risk Low-risk High-risk
1 ✓a < 10− 100 Least good fit
2 ✓ ✓ ≈ 10− 5 Implausible parameterisation
3 ✓ ✓ < 10− 100 Poor fit
4 ✓ ✓ 0.955 Good fit
5 ✓ ✓ ✓ ✓ 0.026 No improvement over Model 4
but more parameters
6 ✓a ✓ ≈ 10− 9
7 ✓ ✓ ✓ 1 Best fit
aModels 1 and 6 have homogeneous risk for all humans, which is equivalent to all humans being “low-risk” ✓ = included as a distinct host category in the model
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crosses the same threshold (Model 4, mean screening).
This is due largely to high levels of underreporting of
passive cases, with an estimated reporting rate of ap-
proximately 26 % (see Additional file 1: Table S2). In
contrast, the long-term active case incidence is domi-
nated by the specificity of the diagnostic algorithm and
the level of active screening. Moving forwards it is cru-
cial to define precisely what “incidence” means in terms
of elimination milestones and to ensure that the number
of cases continues to decline following elimination as a
public health problem.
Discussion
Implications for 2020 goals
Model fitting indicates that the past efforts of active de-
tection and treatment in Yasa-Bonga and Mosango
health zones of the DRC have halved (52-53 %
reduction) the number of new infections over a 15-year
period. Although this figure is lower than the 63 % re-
duction in reported cases across these health zones be-
tween 2000–2012, this difference is due, in part, to the
level and timing of screening which impact upon report-
ing in addition to the impact of underreporting. Despite
this success however, these simulations suggest that we
are unlikely to meet the elimination goal in these health
zones by 2020 if current strategies continue unchanged;
this includes sustaining the highest level (53.1 %) of
yearly active screening. The results of fitting multiple
model formulations to the data predicts that with the
highest levels of screening the elimination target will be
met between 2059 and 2092. If future screening follows
the mean (29.6 %) then the predicted elimination year is
increased, lying between 2098 and 2199. Whilst there
has been almost 80 % reduction in reported cases for the
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whole DRC between 1998–2012 [7], Bandundu province
of DRC remains one of the regions with the highest
HAT burden globally, and it is therefore anticipated to
be one of the toughest areas in which to meet this
target.
This article presents a suite of models focussed on elu-
cidating the underlying transmission pathways of T. b.
gambiense. To compare and fit competing model struc-
tures, certain aspects which may impact transmission of
this disease were not included and may account for
some of the differences seen between the model output
and data. We have implicitly assumed spatial homogen-
eity, such that all locations within the health zones ex-
perience the same level of screening and have the same
underlying epidemiological risks. Spatial heterogeneity
may account for the larger peak in active incidence seen
in 2009 if the increase in screening was achieved
through screening new areas rather than increasing the
proportion screened in towns that previously partici-
pated. Throughout we have treated the data from these
two health zones (which cover 6160 km2 [34, 35]) as a
single population, whereas in reality it is comprised of
multiple towns and villages. This spatial heterogeneity is
computationally intensive to capture, but may have an
effect on our inferred parameters and hence our long-
term predictions. However, given that many regions fol-
low the aggregate pattern, we do not expect a qualitative
change to our results. Likewise, other spatial differences
in the human population and tsetse habitat were not
included and could affect model outcomes. It was
also assumed that the passive detection rate and
reporting levels were unaffected by active screening
campaigns, however it may be that passive detection
becomes greater with the increase in awareness of
HAT in the area.
The model made use of constant human population
sizes across the health zones, as very limited demo-
graphic data for these regions were available. It is be-
lieved that small variation in total population size, for
example a low-level population growth rate, would not
qualitatively alter the results, however longitudinal
estimates of the demography of the population at a
health zone level would strengthen future modelling by
providing reliable values for the population sizes over
time.
The model indicates that underreporting of HAT is
high (possibly as much as 77 % underreporting), which
is in line with values suggested in the literature [40]. Al-
though it is not possible to determine whether this is
due to under-detection of disease and a subsequent lack
of identification of cause of death, or errors in data
reporting. Additional data, such as testing for HAT in-
fection posthumously, would provide future models with
more robust estimates for this value.
Unfortunately there are currently no published esti-
mates within the DRC for tsetse or animal T. b. gam-
biense infection prevalences. Whilst the model generates
extremely low tsetse prevalences, in the order of 10− 4 to
10− 5, limited data for other HAT endemic countries has
indicated that infection levels of T. b. gambiense in tse-
tse were found to be at similarly low levels, of the order
10− 4 [4]. New data on infection in tsetse and/or animals
would enable model validation and refinement. There
remain substantial uncertainties in many components of
HAT transmission including relative risk of different
groups of people, vector competence and the ratio of
tsetse to hosts. Another modelling study which was fit-
ted to data from Guinea [ref - 50 (Pandey)] also con-
cluded that an animal reservoir cannot be ruled out.
Gathering empirical data will be vital to improve and re-
fine models and their predictions.
Future for Gambian HAT
This article presents results based on defining “elimin-
ation as a public health problem” as the point where the
number of new infections falls below 1 per 10,000 per
year. In practice, it is hard to determine when this mile-
stone is achieved based on active and/or passive case
reporting. Passive case incidence will drop below this
threshold before this target is actually met and is contin-
gent upon the level of underreporting. The number of
cases identified by active case detection will be highly
dependent upon specificity and screening levels espe-
cially towards the “end-game” stages of elimination.
Without introducing more specific diagnostics or diag-
nostic algorithms, it is possible that reported active inci-
dence may never fall below the 1 per 10,000 threshold
due to false positives. Mechanistic models can help de-
termine the incidence of new infections and so, in the
future, could provide guidance as to when controls may
be lifted without recrudescence occurring.
Modelling indicates that heterogeneities in the human
population play an important role in recent disease dy-
namics. This points towards ways of improving current
active detection such as ensuring more of the population
Table 3 For each biologically feasible model, this table gives
the mean R0
2 values in the absence of annual active screening as
well as the predicted elimination years under either mean
screening levels or maximum screening levels. 95 % credible
intervals are given in brackets
Model Pre-active screen R0
2 Elimination as a public health problem year
Mean screen Max screen
1 1.024 [1.023, 1.025] 2014 [2014, 2015] 2013 [2013,2015]
4 1.046 [1.038, 1.056] 2140 [2103, 2199] 2074 [2060, 2092]
6 1.005 [1.005, 1.005] 2077 [2072, 2101] 2059 [2050,2069]
7 1.040 [1.032, 1.048] 2124 [2098, 2176] 2072 [2059,2091]
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is screened, in particular those who have typically not
presented at or those who are high-risk/or those who
are high-risk. These results are in line with the theoret-
ical modelling investigation by Stone and Chitnis [ref -
51] which suggests targeting high-risk individuals in
screening is necessary (and may, in some cases, be suffi-
cient) to disrupt transmission. Model results here sug-
gest that around 8-9 % of the human population are
both more exposed to the bites of tsetse and never par-
ticipate in active screening; this estimate is generated by
model fitting rather than social quantification. Moving
forwards it would be beneficial to find suitable methods
to identify such individuals so that they may be targeted
during screening. Additionally, new improvements in
drugs for the future treatment of HAT [9] may help im-
prove participation in screening, for example if new
drugs could be administered on an out-patient basis, or
if the rest period following treatment were reduced.
These two health zones have not employed vector
control as part of their intervention programme, and
whilst promising new methods of tsetse control are
emerging (e.g. use of tiny targets [43, 44]) their use was
not modelled here. Tsetse control through tiny targets
has not yet been implemented at scale in this area but
has shown great potential at significantly reducing tsetse
densities (up to 90 %) over a large area [43], offering a
promising complementary strategy and are currently be-
ing trialled in Yasa-Bonga. In another modelling study,
Pandey et al [ref - 50] find that by using a two-pronged
strategy, combining active screening and vector control,
the Boffa focus in Guinea is likely to meet the 2020
elimination target. In the work presented here, it is un-
clear from fitting to the DRC data, whether animals play
an active role in transmission in this area, however tsetse
control provides an intervention that circumvents het-
erogeneities in the human (and possible animal reser-
voir) population(s) by reducing biting pressure towards
all hosts. Since it is a novel strategy to this area, the
quantitative impact of vector control on disease cannot
be directly assessed, however by utilising and fitting to
data sets (both human case data and vector data) from
regions with existing vector control (such as Uganda and
Guinea), appropriate extensions to the existing model can
be made and used to extrapolate into regions, like Yasa-
Bonga and Mosango, where pre-vector control dynamics
are known [27].
Conclusions
A mechanistic modelling framework for Gambian HAT
was developed to assess the success of on-going active
detection and treatment in Bandundu Province of the
DRC and predict the time until HAT will be eliminated
as a public health problem in the region. It was con-
cluded that active detection campaigns in this area are
responsible for halving the number of new infections be-
tween 1998 and 2012, however this high-endemicity re-
gion is unlikely to achieve the WHO goal of 1 case per
10,000 people per year by 2020. The suite of models pre-
dict that this elimination target will only be reached by
2059–2092, even if the highest levels of screening
achieved between 2000 and 2012 (53.1 %) continue every
year. This suggests that additional strategies such as vec-
tor control and/or improved screening of the human
population are required to accelerate progress against
Gambian HAT.
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